Recent use of oral contraceptives and the risk of multiple sclerosis.
about
Temporal trends in the incidence of multiple sclerosis: a systematic reviewEnvironmental risk factors for multiple sclerosis. Part II: Noninfectious factorsMissing and Possible Link between Neuroendocrine Factors, Neuropsychiatric Disorders, and MicrogliaSex hormones: a role in the control of multiple sclerosis?Validity of diagnostic coding within the General Practice Research Database: a systematic reviewMortality of patients with multiple sclerosis: a cohort study in UK primary careSex differences in autoimmune diseases.Multiple sclerosis and pregnancy: maternal considerations.Genetics and pathogenesis of multiple sclerosis.Risk factors associated with the onset of relapsing-remitting and primary progressive multiple sclerosis: a systematic reviewMultiple sclerosis; a disease of reproductive-aged women and the dilemma involving contraceptive methods.Sex-related factors in multiple sclerosis susceptibility and progression.Oral Contraceptives and Multiple Sclerosis/Clinically Isolated Syndrome SusceptibilityAlgorithms to estimate the beginning of pregnancy in administrative databasesExpert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancyEpidemiology of multiple sclerosis: results from a large observational study in the UK.Fetal risks related to the treatment of multiple sclerosis during pregnancy and breastfeeding.Assessing the Risk Factors for Multiple Sclerosis in Women of Reproductive Age Suffering the Disease in Isfahan ProvinceFemale-specific issues in multiple sclerosis.Gender and sex hormones in multiple sclerosis pathology and therapy.Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter study.Beginning and duration of pregnancy in automated health care databases: review of estimation methods and validation results.Pregnancy and multiple sclerosis: from molecular mechanisms to clinical application.Optic neuritis secondary to antiandrogen therapy.Breastfeeding, ovulatory years, and risk of multiple sclerosis.Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping.Hormone therapy use and physical quality of life in postmenopausal women with multiple sclerosisInsights into Initial Demyelinating Episodes of Central Nervous System during Puerperium.Pregnancy: Effect on Multiple Sclerosis, Treatment Considerations, and Breastfeeding.Oral contraceptives and MS disease activity in a contemporary real-world cohort.Hormones and MS: Risk factors, biomarkers, and therapeutic targets.Drug exposure and the risk of multiple sclerosis: A systematic review.Evaluating sex hormones and cytokine profile in Egyptian females with relapsing-remitting multiple sclerosis
P2860
Q22241655-31A25388-A202-4C03-B9DA-611036831A93Q22252931-807CC5AC-3EC8-4C24-B0A5-6E805B22DBFEQ30452038-1C003545-FF38-49F7-B7CF-16C9B6400395Q31037759-CDCFACCE-1E2C-451A-838D-9F9ECBFE6B06Q33689383-961E6AEF-9649-40E2-8900-0D3317BF6AB5Q33990847-A12369EC-33BA-4B79-9179-206685D6B514Q34498866-32AD0C22-0F73-4B61-90B3-DCD804FCC389Q34639869-49343DA5-C435-49F0-9CB7-F5E792414548Q35004746-0688B348-0719-4A47-8F48-0736CEB88960Q35087429-80891A0F-C7BF-4B6B-87D9-D47860F1BF51Q35173110-FC63D2CE-4CE4-454F-B4EB-29F44260AB16Q35619427-7AD38EDE-3E98-42A5-A86C-0CF575454D19Q35947785-EACE3CED-C188-4BCB-B742-621EB1F27AFAQ36219433-DD927720-4AE3-4E69-98A5-FEF4475D9263Q36298897-FAB7C600-CEF0-4EC7-B42F-E8A2D2BE487DQ36621581-FC42CDAE-C0A5-489A-8ABF-B2A820DC835CQ36688987-130CA6C9-B451-4320-95CA-9F618516ECBFQ36732954-19801359-107C-4EFF-B1F6-233DF45726FAQ37174067-0AF25FD9-49AC-4F0A-BFCB-A8185B308B2FQ37209917-EED4A45C-A3D1-459A-8B13-278F452CCC8CQ37721393-78E44C53-516E-4A1E-B967-8DE6AF857BD0Q38334947-14326B44-D422-4F20-8FE8-3EDF27803D37Q38921991-0AF40D7E-91C3-4F94-B388-E9357319BA31Q39063431-6D69AF3B-DC97-4DC3-92FD-0DEFB1BE206AQ40125259-F7096904-87B8-460C-84E8-5AE5CB7D2EE1Q40166499-107EE772-86AE-45B4-A723-79A05A8A1218Q40590735-C7B2332F-AEF9-47BA-A1E0-4E07A0F0B328Q41295403-50B66C77-CB59-4653-9C5B-88A799862F75Q46145241-FD8DCB9F-17FE-4A41-959F-C32123B2C960Q46640069-F3DF3047-791B-4681-8F81-233EC6DBD11DQ47747865-AD20F5F8-0683-47A6-9FE4-82FAE17C2B17Q47930462-A00F66C1-DAA6-4AF7-B65B-4070659AD904Q59132182-51908E67-812E-4E16-AE07-CF52782F64F5
P2860
Recent use of oral contraceptives and the risk of multiple sclerosis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Recent use of oral contraceptives and the risk of multiple sclerosis.
@en
Recent use of oral contraceptives and the risk of multiple sclerosis.
@nl
type
label
Recent use of oral contraceptives and the risk of multiple sclerosis.
@en
Recent use of oral contraceptives and the risk of multiple sclerosis.
@nl
prefLabel
Recent use of oral contraceptives and the risk of multiple sclerosis.
@en
Recent use of oral contraceptives and the risk of multiple sclerosis.
@nl
P50
P1433
P1476
Recent use of oral contraceptives and the risk of multiple sclerosis.
@en
P2093
Michael J Olek
Miguel A Hernán
P304
P356
10.1001/ARCHNEUR.62.9.1362
P577
2005-09-01T00:00:00Z